Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
169.2 EUR | +0.45% | +0.53% | +17.70% |
11:25am | MERCK KGAA : Receives a Buy rating from UBS | ZD |
10:14am | Merck KGaA: acquisition of U.S.-based Mirus Bio | CF |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.70% | 79.38B | |
+9.28% | 8.74B | |
-14.24% | 4.94B | |
+49.95% | 4.7B | |
+5.96% | 3.98B | |
-23.57% | 2.28B | |
+15.19% | 2.28B | |
+17.77% | 2.14B | |
-32.28% | 2.12B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- MRK Stock
- News Merck KGaA
- Transcript : MERCK Kommanditgesellschaft auf Aktien - Analyst/Investor Day